Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells.
Mirza H
,
Yatsula V
,
Bahou WF
.
???displayArticle.abstract???
Proteolytically cleaved receptors, typified by the functional thrombin receptor (TR), represent a novel class of receptors that mediate signaling events by functional coupling to G proteins. Northern blot analysis completed with a human proteinase activated receptor-2 (PAR-2) cDNA as probe demonstrated the approximately 3.5kb PAR-2 transcript in total cellular RNA from human umbilical vein endothelial cells (HUVEC). Microspectrofluorimetry using Fura2-loaded HUVEC demonstrated a dose-dependent elevation in intracellular calcium transients ([Ca2+]i) to murine PAR39-44 (SLIGRL, putative neoligand after cleavage), with an approximate EC50 of 30 microM, and evidence for homologous desensitization with complete recovery at 45 min. Xenopus oocytes microinjected with TR cRNA failed to respond to 200 microM PAR39-44, and TR-targeted antisense oligonucleotides specifically abrogated thrombin-induced but not PAR39-44-mediated [Ca2+]i, excluding the possibility that TR/PAR-2 cell-surface coexpression was structurally linked. HUVEC incubated with PAR39-44 demonstrated a dose- and time-dependent mitogenic response similar to that seen with thrombin or TR42-47 (TR-activating peptide, SFLLRN). Preactivation of HUVEC with either PAR39-44 or thrombin resulted in heterologous desensitization to the corresponding agonist, an effect that was mediated primarily by TR internalization as evaluated by immunofluorescence and quantitative ELISA. These results ascribe a previously unrecognized function to the PAR-2 receptor, imply that a natural enzyme agonist may circulate in plasma, and suggest the presence of an additional regulatory mechanism controlling receptor activation events in vascular endothelial cells.
Axelrod,
Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells.
1989, Pubmed
Axelrod,
Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells.
1989,
Pubmed
Bahou,
cDNA cloning and molecular characterization of MSE55, a novel human serum constituent protein that displays bone marrow stromal/endothelial cell-specific expression.
1992,
Pubmed
Bahou,
The thrombin receptor extracellular domain contains sites crucial for peptide ligand-induced activation.
1993,
Pubmed
Bahou,
The VLA-2 (alpha 2 beta 1) I domain functions as a ligand-specific recognition sequence for endothelial cell attachment and spreading: molecular and functional characterization.
1994,
Pubmed
Bahou,
Identification of a novel thrombin receptor sequence required for activation-dependent responses.
1994,
Pubmed
,
Xenbase
Brown,
Tryptase-induced mitogenesis in airway smooth muscle cells. Potency, mechanisms, and interactions with other mast cell mediators.
1995,
Pubmed
Carney,
Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides.
1992,
Pubmed
Chaikof,
Growth-related responses in arterial smooth muscle cells are arrested by thrombin receptor antisense sequences.
1995,
Pubmed
Chambard,
Two growth factor signalling pathways in fibroblasts distinguished by pertussis toxin.
,
Pubmed
Chang,
Human plasmin induces a receptor-mediated arachidonate release coupled with G proteins in endothelial cells.
1993,
Pubmed
Chen,
Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode.
1994,
Pubmed
,
Xenbase
Chen,
Mitogenic activity of blood components. I. Thrombin and prothrombin.
1975,
Pubmed
Coller,
Thrombin receptor activating peptides: importance of the N-terminal serine and its ionization state as judged by pH dependence, nuclear magnetic resonance spectroscopy, and cleavage by aminopeptidase M.
1992,
Pubmed
Coughlin,
Protease-activated receptors start a family.
1994,
Pubmed
Danø,
Plasminogen activators, tissue degradation, and cancer.
1985,
Pubmed
Davey,
Actions of thrombin and other coagulant and proteolytic enzymes on blood platelets.
1967,
Pubmed
Estreicher,
Characterization of the cellular binding site for the urokinase-type plasminogen activator.
1989,
Pubmed
Gerszten,
Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface.
1994,
Pubmed
,
Xenbase
Glenn,
Thrombin active site regions required for fibroblast receptor binding and initiation of cell division.
1980,
Pubmed
Grynkiewicz,
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
1985,
Pubmed
Hein,
Intracellular targeting and trafficking of thrombin receptors. A novel mechanism for resensitization of a G protein-coupled receptor.
1994,
Pubmed
Ishii,
Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling.
1993,
Pubmed
Kim,
Mouse fibroblasts defective in thrombin mitogenesis possess functional proteolytically activated receptor for thrombin: requirement for a second signaling pathway.
1994,
Pubmed
Lee,
Cross-talk between m1 muscarinic acetylcholine and beta 2-adrenergic receptors. cAMP and the third intracellular loop of m1 muscarinic receptors confer heterologous regulation.
1993,
Pubmed
Liotta,
Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.
1991,
Pubmed
Martin,
Protease activation during apoptosis: death by a thousand cuts?
1995,
Pubmed
McGowan,
Modified platelet responses to thrombin. Evidence for two types of receptors or coupling mechanisms.
1986,
Pubmed
McNamara,
Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor.
1993,
Pubmed
Molino,
Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G.
1995,
Pubmed
Morris,
Cross-regulation between G-protein-coupled receptors. Activation of beta 2-adrenergic receptors increases alpha 1-adrenergic receptor mRNA levels.
1991,
Pubmed
Mosmann,
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.
1983,
Pubmed
Nagy,
Contraction of human brain endothelial cells induced by thrombogenic and fibrinolytic factors. An in vitro cell culture model.
1995,
Pubmed
Ngaiza,
A 14 amino acid peptide derived from the amino terminus of the cleaved thrombin receptor elevates intracellular calcium and stimulates prostacyclin production in human endothelial cells.
1991,
Pubmed
Nystedt,
Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2.
1995,
Pubmed
Nystedt,
Molecular cloning of a potential proteinase activated receptor.
1994,
Pubmed
,
Xenbase
Nystedt,
The mouse proteinase-activated receptor-2 cDNA and gene. Molecular cloning and functional expression.
1995,
Pubmed
Pohjanpelto,
Stimulation of DNA synthesis in human fibroblasts by thrombin.
1978,
Pubmed
Pustell,
A convenient and adaptable microcomputer environment for DNA and protein sequence manipulation and analysis.
1986,
Pubmed
Reich,
Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells.
1988,
Pubmed
Scarborough,
Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function.
1992,
Pubmed
,
Xenbase
Schmeidler-Sapiro,
Mitogenic effects of coagulation factor XII and factor XIIa on HepG2 cells.
1991,
Pubmed
Shuman,
Thrombin-cellular interactions.
1986,
Pubmed
Smith,
Signal transduction pathways for B1 and B2 bradykinin receptors in bovine pulmonary artery endothelial cells.
1995,
Pubmed
Tesfamariam,
Involvement of the "tethered ligand" receptor in thrombin-induced endothelium-mediated relaxations.
1993,
Pubmed
Vassallo,
Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides.
1992,
Pubmed
Vouret-Craviari,
Synthetic alpha-thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis.
1992,
Pubmed
,
Xenbase
Vu,
Domains specifying thrombin-receptor interaction.
1991,
Pubmed
,
Xenbase
Vu,
Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.
1991,
Pubmed
,
Xenbase
Wang,
Blocking of collagenase secretion by estramustine during in vitro tumor cell invasion.
1988,
Pubmed
Weksler,
Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A 23187.
1978,
Pubmed
Woolkalis,
Regulation of thrombin receptors on human umbilical vein endothelial cells.
1995,
Pubmed
Zacharias,
Thrombin, phorbol ester, and cAMP regulate thrombin receptor protein and mRNA expression by different pathways.
1995,
Pubmed
Zhong,
Molecular cloning of the rat vascular smooth muscle thrombin receptor. Evidence for in vitro regulation by basic fibroblast growth factor.
1992,
Pubmed
Zucker,
Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiologic regulation of angiogenesis.
1995,
Pubmed